Earnings Release Scheduled for May 15, 2014 After Market Close
Conference Call to Follow May 15th at 5:00 PM Eastern Time
SALT LAKE CITY, May 7, 2014 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), a biomaterials company focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices, announced today that it will report financial results for the first quarter ended March 31, 2014 after the market close on Thursday, May 15, 2014. A press release reporting such results is planned for issuance at that time.
The Company also announced that it will host an investor conference call to discuss the results on the same day at 5:00 PM Eastern Time. The Company invites all interested parties to join the call on Thursday, May 15th at 5:00 p.m. Eastern Time by dialing 1- (855) 455-6055, any time after 4:50 p.m. Eastern on May 15th. The Conference ID is 43015187. International callers should dial (484) 756-4308. A live audio webcast of the call will be available through a link on the Company's web site, at http://investors.amedica.com/events.cfm. If you are unable to participate during the live teleconference, the call will be archived for one week. The audio archive can be accessed by calling (855) 859-2056 in the U.S. or (404) 537-3406 from outside the U.S. The Conference ID for the audio replay is 43015187.
About Amedica Corporation
Amedica is a commercial biomaterials company focused on using its silicon nitride technology platform to develop, manufacture and sell a broad range of medical devices. Amedica markets spinal fusion products and is developing product candidates for use in total hip and knee joint replacements. Amedica operates an ISO 13485 certified manufacturing facility and its spine products are FDA cleared, CE marked, and currently marketed in the U.S. and select markets in Europe and South America.
The Company's web site for news releases and other information is www.amedica.com.
CONTACT: Amedica Corporation Gordon Esplin VP, Finance (801) 839-3516 firstname.lastname@example.org